Jump Financial’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-140,817
Closed -$2.97M 2168
2025
Q4
$2.97M Buy
+140,817
New +$3.82M 0.04% 536
2025
Q3
Sell
-17,424
Closed -$1.3M 2013
2025
Q2
$1.3M Buy
17,424
+9,033
+108% +$799K 0.01% 867
2025
Q1
$791K Buy
8,391
+3,380
+67% +$247K 0.01% 909
2024
Q4
$363K Buy
+5,011
New +$307K 0.01% 1230
2024
Q1
Sell
-7,572
Closed -$734K 2111
2023
Q4
$734K Sell
7,572
-28,216
-79% -$5.49M 0.02% 867
2023
Q3
$7.37M Buy
35,788
+2,135
+6% +$347K 0.27% 56
2023
Q2
$4.84M Buy
33,653
+27,966
+492% +$4.18M 0.18% 121
2023
Q1
$1.17M Sell
5,687
-7,393
-57% -$1.26M 0.05% 533
2022
Q4
$2.26M Buy
13,080
+3,020
+30% +$619K 0.12% 237
2022
Q3
$2.41M Buy
10,060
+6,072
+152% +$1.41M 0.09% 320
2022
Q2
$1.55M Buy
+3,988
New +$2M 0.07% 412

Other funds holding LABD

Jump Financial's LABD Position: Q1 2026 in Review

Jump Financial sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026, closing a stake of 140,817 shares — an estimated $2.97M sold.

Jump Financial first reported a position in LABD in Q2 2022 and held it in 11 quarters. The position peaked at $7.37M in Q3 2023. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Jump Financial reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 140,817 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $2.97M.
  • Jump Financial first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2022 and held it in 11 quarters.
  • Jump Financial's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $7.37M in Q3 2023.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.